SCHEMBL20127445

SCHEMBL20127445

c1ccc2c(-c3c4ccccc4c(-c4c5ccccc5cc5c4oc4ccccc45)c4ccccc34)c3ccc4ccccc4c3cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
HSD17B10 Q99714 3/20 0.46
HIF1A Q16665 1/20 0.46
CYP1B1 Q16678 1/20 0.46
SOS1 Q07889 1/20 0.44
AHR P35869 2/20 0.41
TDP1 Q9NUW8 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HPRT1 P00492 3/20 0.39
KDM4E B2RXH2 6/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 3/20 0.39
TSHR P16473 2/20 0.39
GLA P06280 2/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HNF4A P41235 1/20 0.38
CYP2A6 P11509 1/20 0.38
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127635 0.95 ALDH1A1 (0.44) ALDH1A1HSD17B10HIF1ACYP1B1SOS1
SCHEMBL10122689 0.92 AHR (0.47) ALDH1A1HSD17B10HIF1ACYP1B1AHR
SCHEMBL20127434 0.91 CYP1B1 (0.41) ALDH1A1HSD17B10HIF1ACYP1B1SOS1
SCHEMBL20127439 0.90 SOS1 (0.46) ALDH1A1HSD17B10HIF1ACYP1B1SOS1
SCHEMBL20127412 0.88 SOS1 (0.47) ALDH1A1HSD17B10HIF1ACYP1B1SOS1
SCHEMBL20127435 0.88 ALDH1A1 (0.44) ALDH1A1HSD17B10HIF1ACYP1B1SOS1
SCHEMBL20127432 0.87 ALOX5 (0.40) ALDH1A1SOS1AHRTDP1L3MBTL1
SCHEMBL10122560 0.86 AHR (0.41) ALDH1A1HSD17B10HIF1ACYP1B1SOS1
SCHEMBL20127674 0.85 SOS1 (0.47) ALDH1A1HSD17B10HIF1ACYP1B1SOS1
SCHEMBL10122563 0.85 ALOX5 (0.41) ALDH1A1HSD17B10HIF1ACYP1B1SOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALDH1A1 476/4885HSD17B10 2025/4885HIF1A 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.